Free Trial
OTCMKTS:USAQ

QHSLab (USAQ) Stock Price, News & Analysis

QHSLab logo
$0.20 +0.01 (+7.37%)
As of 05/5/2025 11:23 AM Eastern

About QHSLab Stock (OTCMKTS:USAQ)

Key Stats

Today's Range
$0.20
$0.20
50-Day Range
$0.15
$0.29
52-Week Range
$0.08
$0.47
Volume
247 shs
Average Volume
21,718 shs
Market Capitalization
$2.12 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

QHSLab, Inc., a medical device technology and software as a service (SaaS) company, focuses on value-based healthcare, informatics, and algorithmic personalized medicine. It develops digital therapeutics and point of care solutions to support remote patient monitoring, address chronic care, and preventive medicine. The company provides quality health score lab expert system (QHSLab), a cloud-based SaaS system, which provides physicians and healthcare organizations with the ability to capture and store patient information electronically in a secure database; and distributes AllergiEnd, a diagnostic related product and allergen immunotherapy treatments to primary care physicians. Its products are designed to promote prevention, early detection, management, and reversal of chronic diseases. The company was formerly known as USA Equities Corp. and changed its name to QHSLab, Inc. in April 2022. QHSLab, Inc. has a strategic alliance with Medical License Factory, LLC. QHSLab, Inc. was incorporated in 1983 and is based in West Palm Beach, Florida.

Receive USAQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for QHSLab and its competitors with MarketBeat's FREE daily newsletter.

USAQ Stock News Headlines

Elon just did WHAT!?
As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they gotten away with it, the Fed and U.S. banks could have seized control of our financial lives forever. But Trump stopped them cold on January 23rd, 2025, when he outlawed CBDCs… Paving the way for Elon Musk's secret master plan.
See More Headlines

USAQ Stock Analysis - Frequently Asked Questions

QHSLab's stock was trading at $0.2480 at the beginning of the year. Since then, USAQ shares have decreased by 19.5% and is now trading at $0.1997.
View the best growth stocks for 2025 here
.

QHSLab, Inc. (OTCMKTS:USAQ) issued its quarterly earnings data on Friday, March, 28th. The company reported ($0.03) earnings per share for the quarter. The business had revenue of $0.63 million for the quarter.

Shares of USAQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that QHSLab investors own include American Premium Mining (HIPH), Ultrack Systems (MJLB), Meta Platforms (META), Isracann Biosciences (ISCNF), International Land Alliance (ILAL), Leef Brands (ICNAF) and Gemini Group Global (GMNI).

Company Calendar

Last Earnings
3/28/2025
Today
5/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
OTCMKTS:USAQ
Fax
N/A
Employees
5
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-470,000.00
Pretax Margin
-3.18%

Debt

Sales & Book Value

Annual Sales
$1.41 million
Price / Cash Flow
N/A
Book Value
($0.04) per share
Price / Book
-4.99

Miscellaneous

Free Float
2,734,000
Market Cap
$2.12 million
Optionable
Not Optionable
Beta
0.67
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

This page (OTCMKTS:USAQ) was last updated on 5/6/2025 by MarketBeat.com Staff
From Our Partners